COMP <GO>
CDRE vs MRK // NET PROFIT MARGIN
Cadre Holdings Inc. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: CDRE 4
— MRK 9
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $31.10 (+3.81%) • MKT CAP: $1.33B
net-margins
7.20%
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDRE VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CDRE | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.50% | 74.80% | -32.30 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.00% | 20.70% | -9.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.5x | 15.3x | +5.20 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 3.42% | +0.85 | CDRE | /fcf-yield <GO> |
| Operating Margin | 11.00% | 34.30% | -23.30 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 7.20% | 28.10% | -20.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 7.50% | 1.30% | +6.20 | CDRE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.16% | 2.26% | -1.10 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.32 | 5.19 | -1.87 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | CDRE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.2 | 51.7 | +16.50 | CDRE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.1x | 18.4x | +9.70 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.33B | $361.02B | -$359.69B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CDRE REV | MRK REV | CDRE GROSS % | MRK GROSS % | CDRE FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $610.3M | $65.01B | 42.5% | 74.8% | $56.8M | $12.36B |
| FY 2024 | $567.6M | $64.17B | 41.1% | 76.3% | $26.1M | $18.10B |
| FY 2023 | $482.5M | $60.12B | — | — | $73.2M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDRE // BETA —
MRK // BETA 0.92